DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Altace (Ramipril) - Adverse Event Reports - Serious Event

 



Index of reports > Cases resulting in a serious event (175)

     Hypotension (21)Renal Failure Acute (16)Blood Creatinine Increased (15)Syncope (14)Vomiting (13)Fall (12)Dyspnoea (11)Dizziness (11)Hyperkalaemia (10)Chest Pain (10)

Below is the selection of adverse event reports related to Altace (Ramipril) that includes cases resulting in a serious event.

 Reports 1 - 25 of 175   Next >>

Adverse event in receiving Altace (Ramipril)

Reported by a individual with unspecified qualification from United Kingdom on 2007-10-31

Patient:

Adverse reactions / side effects: Renal Failure, Vomiting, Dehydration, Hypotension, Abdominal Distension, Circulatory Collapse, Pancreatitis

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Altace
    Dosage: 10 mg, qd
    Administration route: Oral
    Indication: Hypertension

Simvastatin
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Hypercholesterolaemia

Clozapine
    Administration route: Oral

Zaponex
    Administration route: Oral

Other drugs received by patient: Amisulpride; Atenolol; Aspirin



Adverse event in male receiving Altace (Ramipril)

Reported by a consumer/non-health professional from United States on 2007-10-24

Patient: male

Adverse reactions / side effects: Tooth Fracture

Suspect drug(s):
Altace
    Administration route: Oral
    Indication: Cardiac Pacemaker Insertion
    Start date: 2006-02-17

Plavix
    Administration route: Oral
    Indication: Cardiac Pacemaker Insertion
    Start date: 2006-02-17
    End date: 2006-06-05

Other drugs received by patient: Aspirin; Coreg



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from United States on 2007-10-23

Patient:

Adverse reactions / side effects: Macular Degeneration

Suspect drug(s):
Altace (Ramipril)



Adverse event in receiving Altace (Ramipril)

Reported by a physician from Argentina on 2007-10-23

Patient:

Adverse reactions / side effects: Productive Cough, Syncope, Fall, Lung Infiltration, Face Injury, Infection

Suspect drug(s):
Altace
    Indication: Hypertension
    Start date: 2007-07-19

Felodipine
    Indication: Hypertension
    Start date: 2007-07-19

Other drugs received by patient: Clarithromycin



Adverse event in receiving Altace (Ramipril)

Reported by a pharmacist from Germany on 2007-10-22

Patient:

Adverse reactions / side effects: Drug Exposure During Pregnancy, Congenital Anomaly

Suspect drug(s):
Altace (Ramipril)



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from France on 2007-10-22

Patient:

Adverse reactions / side effects: Cryptogenic Organising Pneumonia, Dyspnoea, Eosinophilic Pneumonia, Bronchomalacia, Asthenia, Cough

Adverse event resulted in: hospitalization

Suspect drug(s):
Altace
    Dosage: 5 mg, qd
    Administration route: Oral
    Indication: Hypertension
    Start date: 2006-11-15
    End date: 2007-01-15

Tenormin
    Dosage: 1 u, qd
    Administration route: Oral
    Start date: 2006-11-15
    End date: 2007-06-13

Kardegic / 00002703 /
    Dosage: 160 mg, qd
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2006-11-15

Tahor
    Dosage: 80 mg, qd
    Administration route: Oral
    Start date: 2006-11-15

Plavix
    Dosage: 75 mg, qd
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2006-11-15
    End date: 2007-01-15



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from United States on 2007-10-22

Patient:

Adverse reactions / side effects: Cardiac Failure

Adverse event resulted in: hospitalization

Suspect drug(s):
Altace
    Dosage: 5 mg, qd
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2007-07-10

Metoprolol Succinate
    Dosage: 100 mg, qd
    Administration route: Oral
    Indication: Cardiac Failure
    Start date: 2007-07-10

Other drugs received by patient: Trombyl; Simvastatin



Adverse event in 59 year old male receiving Altace (Ramipril)

Reported by a health professional (non-physician/pharmacist) from Canada on 2007-10-19

Patient: 59 year old male

Adverse reactions / side effects: Angioedema, Face Oedema, Dysphonia, Tongue Oedema, Cardiac Disorder

Suspect drug(s):
Crestor
    Administration route: Oral

Altace
    Administration route: Oral

Other drugs received by patient: Adalat CC; Aspirin; Calcium; Vitamin D; Multi-Vitamins; Doxepin Hydrochloride; Hydrodiuril; Plavix



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from United Kingdom on 2007-10-18

Patient:

Adverse reactions / side effects: Tinnitus, Arthralgia, Oedema Peripheral, Feeling of Body Temperature Change, Paraesthesia

Suspect drug(s):
Altace (Ramipril)

Other drugs received by patient: Istin; Ranitidine HCL



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from United States on 2007-10-18

Patient:

Adverse reactions / side effects: HIP Fracture, Fall, Renal Failure Acute

Adverse event resulted in: hospitalization

Suspect drug(s):
Altace
    Dosage: 1.25 mg, qd
    Administration route: Oral
    Indication: Hypertension
    End date: 2007-06-18

Burinex
    Dosage: 5 mg, qd
    Administration route: Oral
    Indication: Cardiac Failure
    End date: 2007-06-18



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from France on 2007-10-17

Patient:

Adverse reactions / side effects: Drug Exposure During Pregnancy, Ventricular Septal Defect

Suspect drug(s):
Altace
    Dosage: 2.5 mg, qd
    Administration route: Oral
    Indication: Hypertension
    End date: 2007-01-01

Levemir
    Dosage: 90 iu, qd
    Indication: Diabetes Mellitus
    End date: 2007-01-01



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from France on 2007-10-17

Patient:

Adverse reactions / side effects: Hypotension, Rectal Haemorrhage, Gastric Ulcer

Adverse event resulted in: hospitalization

Suspect drug(s):
Altace
    Dosage: 1 u, qd
    Administration route: Oral
    Indication: Hypertension

Lasix
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Cardiac Failure

Previscan / 00789001 /
    Dosage: 25 mg, qd
    Administration route: Oral
    Indication: Thrombosis
    End date: 2006-10-13

Previscan / 00789001 /
    Start date: 2006-10-15

Aldactone
    Dosage: 1 u film-coated tablet
    Administration route: Oral
    Indication: Cardiac Failure

Elisor
    Dosage: 1 u tablet,qd
    Administration route: Oral
    Indication: Hypercholesterolaemia



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from United States on 2007-10-17

Patient:

Adverse reactions / side effects: Blood Pressure Increased, Malaise, Diarrhoea, Dyspepsia, Dizziness, Asthenia

Suspect drug(s):
Altace
    Dosage: 6.25 mg, qd
    Administration route: Oral
    Indication: Blood Pressure
    Start date: 2007-09-17
    End date: 2007-09-18

Altace
    Dosage: 7.5 mg, qd
    Administration route: Oral

Altace
    Dosage: 5 mg, qd
    Administration route: Oral



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from United Kingdom on 2007-10-15

Patient:

Adverse reactions / side effects: Self-Injurious Ideation

Adverse event resulted in: life threatening event

Suspect drug(s):
Altace (Ramipril)



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from France on 2007-10-15

Patient:

Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Jaundice, Scratch, Pruritus, Alanine Aminotransferase Increased, Impetigo, Glomerulonephritis Membranous, Hepatitis Cholestatic, Gamma-Glutamyltransferase Increased, Aspartate Aminotransferase Increased

Adverse event resulted in: hospitalization

Suspect drug(s):
Altace
    Dosage: unk, qd
    Administration route: Oral
    Start date: 2006-06-15
    End date: 2007-06-10

Chloraminophene
    Dosage: 12 mg, qd
    Administration route: Oral
    Indication: Glomerulonephritis
    Start date: 2007-02-15
    End date: 2007-03-15

Tahor
    Dosage: 20 mg, unk
    Administration route: Oral
    Start date: 2006-06-15
    End date: 2007-06-10

Effexor / 01233802 /
    Dosage: unk, qd
    Start date: 2006-06-15
    End date: 2007-06-10

Other drugs received by patient: Aldactone; Lasix; Levothyrox



Adverse event in receiving Altace (Ramipril)

Reported by a physician from Russian Federation on 2007-10-11

Patient:

Adverse reactions / side effects: Pain in Extremity, Intermittent Claudication

Adverse event resulted in: hospitalization

Suspect drug(s):
Altace (Ramipril)

Other drugs received by patient: Crestor



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from United Kingdom on 2007-10-10

Patient:

Adverse reactions / side effects: Dysphagia, Oropharyngeal Swelling, Rhinitis

Suspect drug(s):
Altace (Ramipril)

Other drugs received by patient: Adcal-D3; Aspirin; Atenolol; Atenolol; Glyceryl Trinitrate; Prednisolone; Rabeprazole Sodium; Simvastatin; Strontium Ranelate



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from Norway on 2007-10-10

Patient:

Adverse reactions / side effects: Hyperkalaemia, Nausea, General Physical Health Deterioration, Acidosis, Abdominal Pain Upper, Blood Glucose Decreased, Dehydration, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Altace (Ramipril)

Other drugs received by patient: Atrovent; Nexium; Glimepiride; Glucophage; Lipitor; Burinex



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from United Kingdom on 2007-10-09

Patient:

Adverse reactions / side effects: Drug Interaction, Somnolence

Suspect drug(s):
Altace
    Dosage: 10 mg, qd
    Administration route: Oral
    Indication: Blood Pressure Increased
    Start date: 2007-06-26

Amlodipine
    Dosage: 5 mg, qd
    Administration route: Oral
    Indication: Blood Pressure Increased
    Start date: 2007-08-17
    End date: 2007-09-06



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from United States on 2007-10-05

Patient:

Adverse reactions / side effects: Inappropriate Schedule of Drug Administration, Headache, Disorientation, Hypoaesthesia, Amnesia, Dyspnoea Exertional, Chest Pain, Oedema Peripheral, Hypoaesthesia Facial, Disturbance in Attention

Suspect drug(s):
Altace
    Dosage: 5 mg, qd
    Administration route: Oral
    Start date: 2007-05-01

Plavix
    Dosage: 75 mg, qd
    Administration route: Oral
    Start date: 2005-09-01
    End date: 2007-04-01

Plavix
    Dosage: 75 mg, qd
    Administration route: Oral
    Start date: 2007-04-01

Asacol
    Dosage: 400 mg, bid
    Administration route: Oral
    Indication: Inflammatory Bowel Disease
    Start date: 2007-05-01

Nexium
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Reflux Oesophagitis
    Start date: 2007-05-01

Other drugs received by patient: Atorvastatin Calcium; Aspirin



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from France on 2007-10-05

Patient:

Adverse reactions / side effects: Phlebitis, Pulmonary Embolism, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Suspect drug(s):
Altace
    Dosage: 1.25 mg, qd
    Administration route: Oral
    Indication: Nephrotic Syndrome

Lasix
    Dosage: unk, qd
    Administration route: Oral
    Indication: Nephrotic Syndrome

Thalidomide
    Dosage: 200 mg, qd
    Administration route: Oral
    Indication: Multiple Myeloma

Aldactone
    Dosage: 75 mg, qd
    Administration route: Oral
    Indication: Nephrotic Syndrome

Other drugs received by patient: Alkeran; Dexamethasone 0.5mg TAB; Previscan / 00789001 /



Adverse event in receiving Altace (Ramipril)

Reported by a physician from Ireland on 2007-10-05

Patient:

Adverse reactions / side effects: Skin Exfoliation

Suspect drug(s):
Altace (Ramipril)

Other drugs received by patient: Epanutin / 00017402 /; Tegretol; Lipitor



Adverse event in receiving Altace (Ramipril)

Reported by a consumer/non-health professional from Belgium on 2007-10-04

Patient:

Adverse reactions / side effects: Epididymitis, Vasculitis, Diffuse Vasculitis, Purpura, Lung Infiltration

Suspect drug(s):
Altace (Ramipril)



Adverse event in receiving Altace (Ramipril)

Reported by a physician from Argentina on 2007-10-04

Patient:

Adverse reactions / side effects: Syncope, Fall, Cough, Face Injury

Suspect drug(s):
Altace
    Indication: Hypertension
    Start date: 2007-07-19

Felodipine
    Indication: Hypertension
    Start date: 2007-07-19

Other drugs received by patient: Clarithromycin



Adverse event in 526 month old male receiving Altace (Ramipril)

Reported by a consumer/non-health professional from United States on 2007-10-02

Patient: 526 month old male, weighing 122.5 kg (269.5 pounds)

Adverse reactions / side effects: Headache, Disorientation, Hypoaesthesia, Accidental Overdose, Amnesia, Dyspnoea Exertional, Chest Pain, Oedema Peripheral, Disturbance in Attention

Suspect drug(s):
Nexium
    Administration route: Oral
    Indication: Gastrooesophageal Reflux Disease
    Start date: 2007-05-01

Plavix
    Administration route: Oral
    Indication: Ischaemic Heart Disease Prophylaxis
    Start date: 2005-09-01
    End date: 2007-04-01

Plavix
    Administration route: Oral
    Start date: 2007-04-01

Asacol
    Administration route: Oral
    Indication: Inflammatory Bowel Disease
    Start date: 2007-05-01

Altace
    Administration route: Oral
    Indication: Thrombosis Prophylaxis
    Start date: 2007-05-01

Other drugs received by patient: Aspirin; Lipitor



 Page 1   Next >>

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009